Abstract:Adipose tissue can be divided anatomically, histologically, and functionally into two major entities white and brown adipose tissues (WAT and BAT, respectively). WAT is the primary energy depot, storing most of the bioavailable triacylglycerol molecules of the body, whereas BAT is designed for dissipating energy in the form of heat, a process also known as non-shivering thermogenesis as a defense against a cold environment. Importantly, BAT-dependent energy dissipation directly correlates with cardiometabolic health and has been postulated as an intriguing target for anti-obesity therapies. In general, adipose tissue (AT) lipid content is defined by lipid uptake and lipogenesis on one side, and, on the other side, it is defined by the breakdown of lipids and the release of fatty acids by lipolysis. The equilibrium between lipogenesis and lipolysis is important for adipocyte and general metabolic homeostasis. Overloading adipocytes with lipids causes cell stress, leading to the recruitment of immune cells and adipose tissue inflammation, which can affect the whole organism (metaflammation). The most important consequence of energy and lipid overload is obesity and associated pathophysiologies, including insulin resistance, type 2 diabetes, and cardiovascular disease. The fate of lipolysis products (fatty acids and glycerol) largely differs between AT: WAT releases fatty acids into the blood to deliver energy to other tissues (e.g., muscle). Activation of BAT, instead, liberates fatty acids that are used within brown adipocyte mitochondria for thermogenesis. The enzymes involved in lipolysis are tightly regulated by the second messenger cyclic adenosine monophosphate (cAMP), which is activated or inhibited by G protein-coupled receptors (GPCRs) that interact with heterotrimeric G proteins (G proteins). Thus, GPCRs are the upstream regulators of the equilibrium between lipogenesis and lipolysis. Moreover, GPCRs are of special pharmacological interest because about one third of the approved drugs target GPCRs. Here, we will discuss the effects of some of most studied as well as "novel" GPCRs and their ligands. We will review different facets of in vitro, ex vivo, and in vivo studies, obtained with both pharmacological and genetic approaches. Finally, we will report some possible therapeutic strategies to treat obesity employing GPCRs as primary target.

Regulation and Function of Adipose Triglyceride Lipase (ATGL) in Cellular Metabolism and Disease

Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology

Adipose Triglyceride Lipase Regulates Adipocyte Lipolysis

Adipose Triglyceride Lipase Regulation: An Overview.

Cdna Cloning, Expression and Regulation Analysis of Goose Adipose Triglyceride Lipase (ATGL) Gene

New Roles of Lkb1 in Regulating Adipose Tissue Development and Thermogenesis

S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes

Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein

Recent Advances on the Role of ATGL in Cancer

Differential transcriptional modulation of biological processes in adipocyte triglyceride lipase and hormone-sensitive lipase-deficient mice

Adipose tissue lipid metabolism: lipolysis

GPCR in Adipose Tissue Function—Focus on Lipolysis

A unified model for regulating lipoprotein lipase activity

Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL

Adipose tissue macrophages in remote modulation of hepatic glucose production

Mutational scanning pinpoints distinct binding sites of key ATGL regulators in lipolysis

Regulation of glucose and lipid metabolism in health and disease

Unmasking crucial residues in adipose triglyceride lipase for coactivation with comparative gene identification-58

Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics

Overexpression of ATGL impairs lipid droplet accumulation by accelerating lipolysis in goat mammary epithelial cells

ATGL Mediated Adipocyte Lipolysis Exacerbates Acute Pancreatitis Severity in Mouse Models and Patients